Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epidemic transmission with quarantine measures: application to COVID-19

View ORCID ProfileS.A. Trigger, E.B. Czerniawski, View ORCID ProfileA.M. Ignatov
doi: https://doi.org/10.1101/2021.02.09.21251288
S.A. Trigger
1Joint Institute for High Temperatures, Russian Academy of Sciences, 13/19, Izhorskaia Str., Moscow 125412, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.A. Trigger
  • For correspondence: satron{at}mail.ru
E.B. Czerniawski
1Joint Institute for High Temperatures, Russian Academy of Sciences, 13/19, Izhorskaia Str., Moscow 125412, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M. Ignatov
2Prokhorov General Physics Institute of the Russian Academy of Sciences, 38 Vavilova St., Moscow, 119991 Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.M. Ignatov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Equations for infection spread in a closed population are found in discrete approximation, corresponding to the published statistical data, and in continuous time in the form of delay differential equations. We consider the epidemic as dependent upon four key parameters: the size of population involved, the mean number of dangerous contacts of one infected person per day, the probability to transmit infection due to such contact and the mean duration of disease. In the simplest case of free-running epidemic in an infinite population, the number of infected rises exponentially day by day. Here we show the model for epidemic process in a closed population, constrained by isolation, treatment and so on. The four parameters introduced here have the clear sense and are in association with the well-known concept of reproduction number in the continuous susceptible– infectious–removed, susceptible–exposed–infectious–removed (SIR, SEIR) models. We derive the initial rate of infection spread from the published statistical data for the initial stage of epidemic, when the quarantine measures were absent. On this basis, we can found the corresponding basic reproduction number mentioned above. Our approach allows evaluating the influence of quarantine measures on free pandemic process that leads to the time-dependent rate of infection and suppression of infection. We found a good correspondence of the theory and reliable statistical data. The initially formulated discrete model, describing epidemic course day by day is transferred to differential form. The conditions for saturation of epidemic are found by solving the delay differential equations. They differ essentially from ones in SIR model due to finite delay, typical for COVID-19 The proposed model opens up the possibility to predict the optimal level of social quarantine measures. The model is quite flexible and it can be extended to more complex cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding for this research

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

I confirm that the submitted work did not require ethical oversight by a dedicated ethics oversight body. All ethical guidlines are completely fulfilled.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All reffered in the manuscript data are free available

https://www.worldometers.info/coronavirus

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted February 12, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epidemic transmission with quarantine measures: application to COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epidemic transmission with quarantine measures: application to COVID-19
S.A. Trigger, E.B. Czerniawski, A.M. Ignatov
medRxiv 2021.02.09.21251288; doi: https://doi.org/10.1101/2021.02.09.21251288
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Epidemic transmission with quarantine measures: application to COVID-19
S.A. Trigger, E.B. Czerniawski, A.M. Ignatov
medRxiv 2021.02.09.21251288; doi: https://doi.org/10.1101/2021.02.09.21251288

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)